Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...

British Pound Struggling At New Resistance

For many weeks running, GBP/USD has been trading sideways in the pink consolidation. After moving higher recently, just what are the chances of the breakout sticking? GBP/USD recently broke above the pink multi-week consolidation, and the bulls didn’...

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...

Morning Market Outlook for Jan. 17, 2024

Stephen Whiteside of TheUpTrend.com looks at Canadian stocks and some struggling blue-chip stocks in the Morning Market Outlook for Wednesday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P 500, NASD...

Africa rising

A lot of resource investors stop listening to corporate presentations when they learn the company’s project is in Africa. More often than not the country risk of exploring for minerals in the “dark continent” (as Africa was known to 1...

McAfee (MFE): Bullish sentiment, poor stock performance

Shares of security software concern McAfee Inc. ( NYSE: MFE , Stock Forum ) have been far from impressive this year. The stock has underperformed the struggling S&P 500 Index (SPX) by roughly 17% on a relative-strength basis during the past 60 trading days. What's more, M...

Skechers Puts its Best Foot Forward with Record Quarterly Sales

Skechers USA reported record global sales for the second quarter. International sales led the way in the quarter with an increase of 19.8% over the same period last year. Lifestyle and performance footwear company Skechers USA Inc. (SKX:NYSE) reported ...

Buzz on the Bullboards: Of interest rates and rebates

Inflation continues to surge out of control to the point where grocery rebates seem to offer little help to struggling Canadians. This holiday-shortened week, markets are adjusting to the U.S. Federal Reserve’s move to raise interest rates. Investors a...
1 2 3 4 5 6 7 8 9 10 ...